Egrifta approved for HIV-associated abdominal lipodystrophy - ONA
Links shared publicly online about this topic.
- 735total visits
Egrifta approved for HIV-associated abdominal lipodystrophy - ONA
View full resource at oncologynurseadvisor.com
Tags: Hormone, Fat, FDA, Merck & Co.
Most Recently Shared on November 11, 2010 at 4:18 pm By:
Egrifta approved for HIV-associated abdominal lipodystrophy http://goo.gl/fb/7J3d9
FDA Approves Egrifta (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy
drugs.com — “Egrifta (tesamorelin) is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Includes Egrifta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 12, 2010 at 1:25 am By:
FDA Approves Egrifta for the Reduction of Excess Abdominal Fat in HIV Patients with Lipodystrophy - http://bit.ly/bYTUCU
FDA Approves Egrifta (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abdominal Fat in HIV-infected Patients with Lipodystrophy
drugs.com — “Egrifta (tesamorelin) is used for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. Includes Egrifta side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on November 12, 2010 at 12:10 am By:
Drugs and Devices OW OW Health
FDA Approves Egrifta (tesamorelin for injection): First and Only Treatment for the Reduction of Excess Abd... http://bit.ly/aGIPwA #drug
Egrifta approved for HIV-associated abdominal lipodystrophy - MPR
empr.com — “Merck and EMD Serono announced that the FDA has approved Egrifta (tesamorelin for injection), a growth hormone releasing factor (GRF) analog, for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy.” View full resource at empr.com
Most Recently Shared on November 11, 2010 at 4:55 pm By:
MPR News: Egrifta approved for HIV-associated abdominal lipodystrophy: Merck and EMD Serono announced that the F... http://bit.ly/ddgVS8
Advertisement
